Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease

Mandira Varma-Basil, Shailendra K D Dwivedi, Krishna Kumar, Rakesh Pathak, Ritika Rastogi, S. S. Thukral, Malini Shariff, V. K. Vijayan, Sunil K. Chhabra, Rama Chaudhary

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Eighty per cent of the cases of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) have an infective aetiology, atypical bacteria including Mycoplasma pneumoniae accounting for 5-10% of these. However, the importance of association of M. pneumoniae with episodes of AECOPD still remains doubtful. The present study was therefore undertaken to delineate the extent of involvement of M. pneumoniae in patients with AECOPD at a referral hospital in Delhi, India. Sputum samples and throat swabs from a total of 100 AECOPD patients attending the Clinical Research Center of Vallabhbhai Patel Chest Institute, Delhi, were collected during a 2-year period (January 2004-June 2006). The samples were investigated for the presence of aerobic bacterial pathogens and M. pneumoniae. Diagnosis of infection with M. pneumoniae was based on culture, serology, direct detection of M. pneumoniae specific antigen and PCR. Bacterial aetiology could be established in 16 of the 100 samples studied. Pseudomonas spp. were recovered from eight cases, Streptococcus pneumoniae from four and Klebsiella spp. from two cases. Acinetobacter sp. and Moraxella catarrhalis were isolated from one case each. Serological evidence of M. pneumoniae infection and/or detection of M. pneumoniae specific antigen were seen in 16 % of the cases. One case with definite evidence of M. pneumoniae infection also had coinfection with Pseudomonas spp. However, no direct evidence of M. pneumoniae infection was found in our study population as defined by culture isolation or PCR. In conclusion, although the serological prevalence of M. pneumoniae infection in our study population was significantly higher than in the control group, there was no direct evidence of it playing a role in AECOPD.

Original languageEnglish
Pages (from-to)322-326
Number of pages5
JournalJournal of Medical Microbiology
Volume58
Issue number3
DOIs
Publication statusPublished - Mar 2009

Fingerprint

Mycoplasma pneumoniae
Chronic Obstructive Pulmonary Disease
Infection
Pseudomonas
Antigens
Moraxella (Branhamella) catarrhalis
Polymerase Chain Reaction
Acinetobacter
Klebsiella
Serology
Pharynx
Streptococcus pneumoniae
Sputum
Coinfection
Population
India
Thorax
Referral and Consultation

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease. / Varma-Basil, Mandira; Dwivedi, Shailendra K D; Kumar, Krishna; Pathak, Rakesh; Rastogi, Ritika; Thukral, S. S.; Shariff, Malini; Vijayan, V. K.; Chhabra, Sunil K.; Chaudhary, Rama.

In: Journal of Medical Microbiology, Vol. 58, No. 3, 03.2009, p. 322-326.

Research output: Contribution to journalArticle

Varma-Basil, M, Dwivedi, SKD, Kumar, K, Pathak, R, Rastogi, R, Thukral, SS, Shariff, M, Vijayan, VK, Chhabra, SK & Chaudhary, R 2009, 'Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease', Journal of Medical Microbiology, vol. 58, no. 3, pp. 322-326. https://doi.org/10.1099/jmm.0.003335-0
Varma-Basil, Mandira ; Dwivedi, Shailendra K D ; Kumar, Krishna ; Pathak, Rakesh ; Rastogi, Ritika ; Thukral, S. S. ; Shariff, Malini ; Vijayan, V. K. ; Chhabra, Sunil K. ; Chaudhary, Rama. / Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease. In: Journal of Medical Microbiology. 2009 ; Vol. 58, No. 3. pp. 322-326.
@article{dcb9ee07fd7f4e17b4d9fec556f400de,
title = "Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease",
abstract = "Eighty per cent of the cases of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) have an infective aetiology, atypical bacteria including Mycoplasma pneumoniae accounting for 5-10{\%} of these. However, the importance of association of M. pneumoniae with episodes of AECOPD still remains doubtful. The present study was therefore undertaken to delineate the extent of involvement of M. pneumoniae in patients with AECOPD at a referral hospital in Delhi, India. Sputum samples and throat swabs from a total of 100 AECOPD patients attending the Clinical Research Center of Vallabhbhai Patel Chest Institute, Delhi, were collected during a 2-year period (January 2004-June 2006). The samples were investigated for the presence of aerobic bacterial pathogens and M. pneumoniae. Diagnosis of infection with M. pneumoniae was based on culture, serology, direct detection of M. pneumoniae specific antigen and PCR. Bacterial aetiology could be established in 16 of the 100 samples studied. Pseudomonas spp. were recovered from eight cases, Streptococcus pneumoniae from four and Klebsiella spp. from two cases. Acinetobacter sp. and Moraxella catarrhalis were isolated from one case each. Serological evidence of M. pneumoniae infection and/or detection of M. pneumoniae specific antigen were seen in 16 {\%} of the cases. One case with definite evidence of M. pneumoniae infection also had coinfection with Pseudomonas spp. However, no direct evidence of M. pneumoniae infection was found in our study population as defined by culture isolation or PCR. In conclusion, although the serological prevalence of M. pneumoniae infection in our study population was significantly higher than in the control group, there was no direct evidence of it playing a role in AECOPD.",
author = "Mandira Varma-Basil and Dwivedi, {Shailendra K D} and Krishna Kumar and Rakesh Pathak and Ritika Rastogi and Thukral, {S. S.} and Malini Shariff and Vijayan, {V. K.} and Chhabra, {Sunil K.} and Rama Chaudhary",
year = "2009",
month = "3",
doi = "10.1099/jmm.0.003335-0",
language = "English",
volume = "58",
pages = "322--326",
journal = "Journal of Medical Microbiology",
issn = "0022-2615",
publisher = "Society for General Microbiology",
number = "3",

}

TY - JOUR

T1 - Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease

AU - Varma-Basil, Mandira

AU - Dwivedi, Shailendra K D

AU - Kumar, Krishna

AU - Pathak, Rakesh

AU - Rastogi, Ritika

AU - Thukral, S. S.

AU - Shariff, Malini

AU - Vijayan, V. K.

AU - Chhabra, Sunil K.

AU - Chaudhary, Rama

PY - 2009/3

Y1 - 2009/3

N2 - Eighty per cent of the cases of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) have an infective aetiology, atypical bacteria including Mycoplasma pneumoniae accounting for 5-10% of these. However, the importance of association of M. pneumoniae with episodes of AECOPD still remains doubtful. The present study was therefore undertaken to delineate the extent of involvement of M. pneumoniae in patients with AECOPD at a referral hospital in Delhi, India. Sputum samples and throat swabs from a total of 100 AECOPD patients attending the Clinical Research Center of Vallabhbhai Patel Chest Institute, Delhi, were collected during a 2-year period (January 2004-June 2006). The samples were investigated for the presence of aerobic bacterial pathogens and M. pneumoniae. Diagnosis of infection with M. pneumoniae was based on culture, serology, direct detection of M. pneumoniae specific antigen and PCR. Bacterial aetiology could be established in 16 of the 100 samples studied. Pseudomonas spp. were recovered from eight cases, Streptococcus pneumoniae from four and Klebsiella spp. from two cases. Acinetobacter sp. and Moraxella catarrhalis were isolated from one case each. Serological evidence of M. pneumoniae infection and/or detection of M. pneumoniae specific antigen were seen in 16 % of the cases. One case with definite evidence of M. pneumoniae infection also had coinfection with Pseudomonas spp. However, no direct evidence of M. pneumoniae infection was found in our study population as defined by culture isolation or PCR. In conclusion, although the serological prevalence of M. pneumoniae infection in our study population was significantly higher than in the control group, there was no direct evidence of it playing a role in AECOPD.

AB - Eighty per cent of the cases of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) have an infective aetiology, atypical bacteria including Mycoplasma pneumoniae accounting for 5-10% of these. However, the importance of association of M. pneumoniae with episodes of AECOPD still remains doubtful. The present study was therefore undertaken to delineate the extent of involvement of M. pneumoniae in patients with AECOPD at a referral hospital in Delhi, India. Sputum samples and throat swabs from a total of 100 AECOPD patients attending the Clinical Research Center of Vallabhbhai Patel Chest Institute, Delhi, were collected during a 2-year period (January 2004-June 2006). The samples were investigated for the presence of aerobic bacterial pathogens and M. pneumoniae. Diagnosis of infection with M. pneumoniae was based on culture, serology, direct detection of M. pneumoniae specific antigen and PCR. Bacterial aetiology could be established in 16 of the 100 samples studied. Pseudomonas spp. were recovered from eight cases, Streptococcus pneumoniae from four and Klebsiella spp. from two cases. Acinetobacter sp. and Moraxella catarrhalis were isolated from one case each. Serological evidence of M. pneumoniae infection and/or detection of M. pneumoniae specific antigen were seen in 16 % of the cases. One case with definite evidence of M. pneumoniae infection also had coinfection with Pseudomonas spp. However, no direct evidence of M. pneumoniae infection was found in our study population as defined by culture isolation or PCR. In conclusion, although the serological prevalence of M. pneumoniae infection in our study population was significantly higher than in the control group, there was no direct evidence of it playing a role in AECOPD.

UR - http://www.scopus.com/inward/record.url?scp=61449161056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449161056&partnerID=8YFLogxK

U2 - 10.1099/jmm.0.003335-0

DO - 10.1099/jmm.0.003335-0

M3 - Article

C2 - 19208881

AN - SCOPUS:61449161056

VL - 58

SP - 322

EP - 326

JO - Journal of Medical Microbiology

JF - Journal of Medical Microbiology

SN - 0022-2615

IS - 3

ER -